DOI QR코드

DOI QR Code

Effect of Metformin on Cell Growth and Differentiation in Cultured Odontoblasts

  • Oh, Chang Young (Oral Biology Research Institute, School of Dentistry, Chosun University) ;
  • Kim, Su-Gwan (Oral Biology Research Institute, School of Dentistry, Chosun University) ;
  • Go, Dae-San (Oral Biology Research Institute, School of Dentistry, Chosun University) ;
  • Yu, Sun-Kyoung (Oral Biology Research Institute, School of Dentistry, Chosun University) ;
  • Kim, Tae-Hoon (Oral Biology Research Institute, School of Dentistry, Chosun University) ;
  • Kim, Chun Sung (Oral Biology Research Institute, School of Dentistry, Chosun University) ;
  • Park, Joo-Cheol (Department of Oral Histology-Developmental Biology and Dental Research Institute, School of Dentistry, Seoul National University) ;
  • Kim, Do Kyung (Oral Biology Research Institute, School of Dentistry, Chosun University)
  • Received : 2017.04.26
  • Accepted : 2017.05.23
  • Published : 2017.06.30

Abstract

Metformin (1,1-dimethylbiguanide hydrochloride), derived from French lilac (Galega officinalis), is a first-line anti-diabetic drug prescribed for patients with type 2 diabetes. However, the role of metformin in odontoblastic cell differentiation is still unclear. This study therefore undertook to examine the effect of metformin on regulating odontoblast differentiation in MDPC-23 mouse odontoblastic cells derived from mouse dental papilla cells. As compared to controls, metformin significantly accelerated the mineralization, significantly increased and accelerated the expressions of ALP and Col I mRNAs, and significantly increased the accelerated expressions of DSPP and DMP-1 mRNAs, during differentiation of MDPC-23 cells. There was no alteration in cell proliferation of MDPC-23 cells, on exposure to metformin. These results suggest that the effect of metformin on MDPC-23 mouse odontoblastic cells derived from mouse dental papilla cells, facilitates the odontoblast differentiation and mineralization, without altering the cell proliferation.

Keywords

References

  1. Lee DS, Yoon WJ, Cho ES, Kim HJ, Gronostajski RM, Cho MI, Park JC. Crosstalk between nuclear factor I-C and transforming growth factor-${\beta}1$ signaling regulates odontoblast differentiation and homeostasis. PLoS One. 2011;6:e29160. doi: 10.1371/journal.pone.0029160.
  2. Mina M1, Kollar EJ. The induction of odontogenesis in non-dental mesenchyme combined with early murine mandibular arch epithelium. Arch Oral Biol. 1987;32:123-127. https://doi.org/10.1016/0003-9969(87)90055-0
  3. Ruch JV. Odontoblast commitment and differentiation. Biochem Cell Biol. 1998;76:923-938. https://doi.org/10.1139/o99-008
  4. Cho JH, Kim SG, Park BS, Go DS, Park JC, Kim DK. MicroRNA-27 promotes odontoblast differentiation via Wnt1 signaling. Int J Oral Biol. 2015;40:197-204. doi: http://dx.doi.org/ 10.11620/IJOB.2015.40.4.197.
  5. Sun Q, Liu H, Lin H, Yuan G, Zhang L, Chen Z. MicroRNA-338-3p promotes differentiation of mDPC6T into odontoblast-like cells by targeting Runx2. Mol Cell Biochem. 2013;377:143-149. doi: 10.1007/s11010-013-1580-3.
  6. Tummers M, Thesleff I. The importance of signal pathway modulation in all aspects of tooth development. J Exp Zool B Mol Dev Evol. 2009;312B:309-319. doi: 10.1002/jez.b.21280.
  7. Wang T, Xu Z. miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun. 2010;402:186-189. doi: 10.1016/j.bbrc.2010.08.031.
  8. Rego DF, Pavan LM, Elias ST, De Luca Canto G, Guerra EN. Effects of metformin on head and neck cancer: a systematic review. Oral Oncol. 2015;51:416-422. doi: 10.1016/j.oraloncology.2015.01.007.
  9. Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi GN, Gonzalez-Angulo AM. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol. 2009;27:3297-3302. doi:10.1200/JCO.2009.19.6410.
  10. Memmott RM, Mercado JR, Maier CR, Kawabata S, Fox SD, Dennis PA. Metformin prevents tobacco carcinogen-induced lung tumorigenesis. Cancer Prev Res (Phila). 2010;3: 1066-1076. doi: 10.1158/1940-6207.CAPR-10-0055.
  11. Jang WG, Kim EJ, Lee KN, Son HJ, Koh JT. AMP-activated protein kinase (AMPK) positively regulates osteoblast differentiation via induction of Dlx5-dependent Runx2 expression in MC3T3E1 cells. Biochem Biophys Res Commun. 2011;404:1004-1009. doi: 10.1016/j.bbrc.2010.12.099.
  12. Jang WG, Kim EJ, Bae IH, Lee KN, Kim YD, Kim DK, Kim SH, Lee CH, Franceschi RT, Choi HS, Koh JT. Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2. Bone. 2011;48: 885-893. doi: 10.1016/j.bone.2010.12.003.
  13. Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ. 2003;327:951-953. doi: http://dx.doi.org/10.1136/bmj.327.7421.951.
  14. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet. 2001;358:893-894. doi: 10.1016/S0140-6736(01)06042-1.
  15. Jeong YK, Kim MS, Lee JY, Kim EH, Ha H. Metformin radiosensitizes p53-deficient colorectal cancer cells through induction of G2/M arrest and inhibition of DNA repair proteins. PLoS One. 2015;10:e0143596. doi: 10.1371/journal.pone.0143596.
  16. Yasmeen A, Beauchamp MC, Piura E, Segal E, Pollak M, Gotlieb WH. Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins. Gynecol Oncol. 2011;121:492-498. doi: 10.1016/j.ygyno.2011.02.021.
  17. Shank JJ, Yang K, Ghannam J, Cabrera L, Johnston CJ, Reynolds RK, Buckanovich RJ. Metformin targets ovarian cancer stem cells in vitro and in vivo. Gynecol Oncol. 2012;127:390-397. doi: 10.1016/j.ygyno.2012.07.115.
  18. Han D, Li SJ, Zhu YT, Liu L, Li MX. LKB1/AMPK/mTOR signaling pathway in non-small-cell lung cancer. Asian Pac J Cancer Prev. 2013;14:4033-4039. doi: http://dx.doi.org/10.7314/APJCP.2013.14.7.4033.
  19. Soranna D, Scotti L, Zambon A, Bosetti C, Grassi G, Catapano A, La Vecchia C, Mancia G, Corrao G. Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist. 2012;17:813-822. doi: 10.1634/theoncologist.2011-0462.
  20. Hwang IC, Park SM, Shin D, Ahn HY, Rieken M, Shariat SF. Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2015;16:595-600. doi: http://dx.doi.org/10.7314/APJCP.2015.16.2.595.
  21. Hanks CT, Fang D, Sun Z, Edwards CA, Butler WT. Dentin-specific proteins in MDPC-23 cell line. Eur J Oral Sci. 1998;106(Suppl 1):260-266. https://doi.org/10.1111/j.1600-0722.1998.tb02185.x
  22. Hanks CT, Sun ZL, Fang DN, Edwards CA, Wataha JC, Ritchie HH, Butler WT. Cloned 3T6 cell line from CD-1 mouse fetal molar dental papillae. Connect Tissue Res. 1998;37:233-249. https://doi.org/10.3109/03008209809002442
  23. Kim DK, Park MG, Lee MH, Yu SK, Park E, Kim S, Lee SA, Moon YH, Kim HJ, Kim CS. MicroRNA analysis during cultured odontoblast differentiation. Int J Oral Biol. 2012;37:146-152.
  24. Kim JW, Lee SA, Go DS, Park BS, Kim SG, Yu SK, Oh JS, Kim CS, Kim J, Park JT, Kim DK. Apoptotic activity of curcumin and EF-24 in HTB-41 human salivary gland epidermoid carcinoma cells. Int J Oral Biol. 2015;40:63-69. doi: http://dx.doi.org/10.11620/IJOB.2015.40.2.063.
  25. Gong Q, Wang R, Jiang H, Lin Z, Ling J. Alteration of microRNA expression of human dental pulp cells during odontogenic differentiation. J Endod. 2012;38:1348-1354. doi: 10.1016/j.joen.2012.06.016.
  26. Kim JS, Park MG, Lee SA, Park SY, Kim HJ, Yu SK, Kim CS, Kim SG, Oh JS, You JS, Kim JS, Seo YS, Chun HS, Park JC, Kim DK. Downregulation of adenomatous polyposis coli by microRNA-663 promotes odontogenic differentiation through activation of Wnt/beta-catenin signaling. Biochem Biophys Res Commun. 2014;446(4):894-900. doi: 10.1016/j.bbrc.2014.03.027.